World's Best Scientists 2026 revealed!
Hossein Ardeschir Ghofrani

Hossein Ardeschir Ghofrani

D-Index & Metrics

Medicine

D-Index
119
Citations
63338
World Ranking
3847
National Ranking
211

Overview

Hossein Ardeschir Ghofrani is affiliated with the University of Giessen in Germany and conducts research primarily in the field of Medicine, with a significant focus on Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. Their work spans several related subfields including Genetics, Molecular Biology, and Hepatology.

The research topics covered by Ghofrani include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiovascular Issues in Pregnancy, Vascular Anomalies and Treatments, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Liver Disease and Transplantation.

Ghofrani has published extensively, with a notable presence in key medical journals. The most frequent publication venues for their research are:

  • The Journal of Heart and Lung Transplantation
  • European Respiratory Journal
  • Pneumologie
  • Pulmonary Circulation
  • Circulation

Noteworthy recent papers authored or co-authored by Ghofrani include:

  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Respiratory Journal
  • Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension, 2023, New England Journal of Medicine
  • ERS statement on chronic thromboembolic pulmonary hypertension, 2020, European Respiratory Journal
  • COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension, 2021, European Respiratory Journal

The scientist often collaborates with several frequent co-authors, including:

  • Werner Seeger
  • Henning Gall
  • Marius M. Hoeper
  • Khodr Tello
  • Manuel J. Richter

Best Publications

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Inhaled iloprost for severe pulmonary hypertension.

    Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam

  • Macitentan and morbidity and mortality in pulmonary arterial hypertension.

    Tomás Pulido;Igor Adzerikho;Richard N. Channick;Marion Delcroix

  • Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

    Hossein-Ardeschir Ghofrani;Andrea M D'Armini;Friedrich Grimminger;Marius M Hoeper

  • Riociguat for the Treatment of Pulmonary Arterial Hypertension

    Hossein-Ardeschir Ghofrani;Nazzareno Galiè;Friedrich Grimminger;Ekkehard Grünig

  • Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

    Nazzareno Galiè;Horst Olschewski;Ronald J. Oudiz;Fernando Torres

  • Tadalafil Therapy for Pulmonary Arterial Hypertension

    Nazzareno Galiè;Bruce H. Brundage;Hossein A. Ghofrani;Ronald J. Oudiz

  • Reversal of experimental pulmonary hypertension by PDGF inhibition.

    Ralph Theo Schermuly;Eva Dony;Hossein Ardeschir Ghofrani;Soni Pullamsetti

  • Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

    Nazzareno Galiè;Joan A. Barberà;Adaani E. Frost;Hossein-Ardeschir Ghofrani

  • Selexipag for the treatment of pulmonary arterial hypertension.

    Olivier Sitbon;Richard Channick;Kelly M Chin;Aline Frey

  • Chronic thromboembolic pulmonary hypertension

    Nick H. Kim;Marion Delcroix;Xavier Jais;Michael M. Madani

  • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly

  • Mechanisms of disease: pulmonary arterial hypertension

    Ralph T. Schermuly;Hossein A. Ghofrani;Martin R. Wilkins;Friedrich Grimminger

  • Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers.

    Marius M. Hoeper;Stephen H. Lee;Robert Voswinckel;Massimiliano Palazzini

  • Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski

  • Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

    Xavier Jaïs;Andrea M. D'Armini;Pavel Jansa;Adam Torbicki

  • Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

    Hossein A. Ghofrani;Ian H. Osterloh;Friedrich Grimminger

  • Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

    Robyn J. Barst;J. Simon R. Gibbs;Hossein A. Ghofrani;Marius M. Hoeper

  • Imatinib for the treatment of pulmonary arterial hypertension.

    Hossein A. Ghofrani;Werner Seeger;Friedrich Grimminger

  • Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 1-Year Results from the CHEST-2 Long-term Extension Study

    Gùrald Simonneau;Andrea D'Armini;Hossein Ghofrani;Friedrich Grimminger

Frequent Co-Authors

Werner Seeger
Werner Seeger University of Giessen
Friedrich Grimminger
Friedrich Grimminger University of Giessen
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Norbert Weissmann
Norbert Weissmann University of Giessen
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Stephan Rosenkranz
Stephan Rosenkranz University of Cologne
Nazzareno Galiè
Nazzareno Galiè University of Bologna
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
Horst Olschewski
Horst Olschewski Medical University of Graz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical studies in the USA doesn’t just mean traditional medical school. There are numerous online pathways in healthcare that offer flexible learning and a range of rewarding careers.

For those considering nursing, online nursing courses provide accessible ways to start a healthcare career or enhance existing skills. Many students look for budget-friendly options such as the cheapest online bsn programs to upgrade their credentials, leading to increased job prospects and higher salaries.

Advanced nursing degrees can be pursued online as well. Those interested in leadership or specialized clinical roles can explore the cheapest dnp programs online. Not already a nurse but want to move directly into advanced practice? You can fast-track your career through direct entry nurse practitioner programs for non-nurses online.

These online pathways make healthcare careers more accessible, allowing students to balance studies with life’s responsibilities while preparing for high-demand roles in the medical field.

Best Scientists Citing Hossein Ardeschir Ghofrani

Trending Scientists

Recently Published Articles